https://li01.tci-thaijo.org/index.php/sehs <h2 class="entry-title" style="text-align: center;"><span style="color: #568ad8;">Science, Engineering and Health Studies</span></h2> <h2 class="entry-title" style="text-align: center;"><span style="color: #568ad8;">(SEHS)</span></h2> <p><strong>Former name: Silpakorn University Science and Technology Journal </strong></p> <p>Science, Engineering and Health Studies (SEHS), originally published as Silpakorn University Science and Technology Journal (since 2007), is a single blind peer-reviewed, open-access journal for original research article, review article and short communication. The journal provides an international forum for reporting innovation, production method, technology, initiative and application of scientific knowledge to all aspects of sciences, engineering, health sciences and related fields. The journal is fully funded by Silpakorn University and therefore no publication fee is required.</p> <p><strong>Journal Abbreviation</strong>: SEHS</p> <p><strong>ISSN (Online)</strong>: 2630-0087 </p> <p><strong>Language</strong>: English</p> <p><strong>Publication Frequency</strong>: Every published article will be immediately available on journal website. (Please note that the article numbering system will be used instead of page numbering, started from Vol. 15) </p> <p><strong><span style="text-decoration: underline;"> </span> </strong></p> <h2 class="entry-title" style="text-align: left;"><span style="color: #3366ff;">Changes to Manuscript Preparation Format</span></h2> <p>(January 9, 2025)</p> <p>Starting with Volume 19, 2025, the format for manuscript preparation will be updated. Authors are advised to refer to the updated Author Guidelines, available under the About the Journal section.</p> <p>Additionally, the reference style will now follow the APA 7th Edition format. Please ensure all submissions comply with these changes.</p> en-US sehs.manager@su.ac.th (Prof. Pornsak Sriamornsak) sehs.manager@su.ac.th (Tuangpohn Jenwithaya-amornwech) Tue, 25 Feb 2025 14:16:54 +0700 OJS 3.3.0.8 http://blogs.law.harvard.edu/tech/rss 60 https://li01.tci-thaijo.org/index.php/sehs/article/view/261792 <p><em>Andrographis paniculata</em> extract, administered at 180 mg/day of andrographolide for 5 consecutive days, has been used to treat mild cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This research formulated 30 mg film-coated tablets of andrographolide, derived from a partially purified extract of Andrographis obtained using the antisolvent technique. The powdered extract was combined with microcrystalline cellulose and colloidal silicon dioxide to create core tablets through the wet granulation method. These core tablets were then film-coated. The Andrographis extract powder contained 40.27±1.18% andrographolide. The average weights of the core and film-coated tablets were 381.9 mg and 392.4 mg, respectively, each contained 31.0 of andrographolide. The average friability and hardness of the core tablets were 0.12±0.01% and 8.7±0.2 kg, respectively. The film-coated tablets completely disintegrated within 23 min, and the distribution of the extracted content in the tablet was uniform. The Andrographis tablets used in this study met all USP criteria.</p> Nattawat Nattapulwat, Phuvamin Suriyaamporn, Praneet Opanasopit, Penpun Wetwitayaklung Copyright (c) 2025 Science, Engineering and Health Studies http://creativecommons.org/licenses/by-nc-nd/4.0 https://li01.tci-thaijo.org/index.php/sehs/article/view/261792 Tue, 25 Feb 2025 00:00:00 +0700